Morrisville CEO talks company growth, timeline for cystic fibrosis treatment

Morrisville-based KNOW Bio ’s respiratory business is moving forward in its fight against antibiotic-resistant pathogens that are all too prevalent for patients with cystic fibrosis (CF) and other lung and respiratory infections. The business has a new name: Novoclem (“the new fight”) Therapeutics. And CEO Anne Whitake r says it could have its lead nitric oxide drug candidate on the market as early as 2021. “We’re really excited about the work that we’re doing and about the potential…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news